Birds eye view29 Oct 2020 09:31
Taking the above is always a sobering way to look at what you have invested in when wild movements in an SP are being experienced.
Fact, we have contracts with our own Government which are odds on to be expanded in the coming weeks due to the reported and aggressive spread of COVID-19.
Fact, we are, until an RNS states otherwise, not monetising huge international markets which offer massive upside to increased revenue when it happens.
Fact, differentiating between flu and Covid 19 will become increasingly important and take on a more urgent need in the coming weeks. We have the ability to deliver this.
Fact, we have gifted individuals running NCYT with a clear plan to maximise shareholder value in the mid to long term utilising cash generated that could only have been dreamt of over such a short period of time.
Fact, with the number of shares in issue, MM’s will have their fun - I noted huge spreads being offered this morning. This is unsettling, however, I suspect we won’t need to wait too long before an RNS will put everyone in the know and calculations can be be redone as to what our MCap should be.
Speculation, Big Pharma may be running their slide rule under NCYT. Don’t rely on this as they will be also busy investing in their own R&D teams which they may believe is a better ROCE.
Final fact, whilst writing this on my IPad, the SP has probably swung +/- 5%....